normal pressure hydrocephalus: A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder (see gait disorders, neurologic), progressive intellectual decline, and urinary incontinence. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of csf including subarachnoid hemorrhage, chronic meningitis, and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp631-3)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1722 |
4. Check minimum number of eventsNone |
1722 |
5. Include endpointsNone |
1722 |
6. Filter based on genotype QC (FinnGen only) |
1722 |
Control definitions (FinnGen only)
- Control exclude
- G6_HYDROCEPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G91
- Name in latin
- Hydrocephalia normotensiva
Similar endpoints
↥List of similar endpoints to
Normal-pressure hydrocephalus
based on the number of shared cases.
Similar with more cases:
- Hydrocephalus
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8138 | 4029 | 4003 |
| Only index persons | 6703 | 3428 | 3275 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.12 | 0.11 |
| Only index persons | 0.13 | 0.13 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 74.05 | 74.92 | 73.17 |
| Only index persons | 73.83 | 74.66 | 72.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1722 | 809 | 913 |
| Unadjusted period prevalence (%) | 0.34 | 0.28 | 0.40 |
| Median age at first event (years) | 73.21 | 73.36 | 73.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1593
- Matched controls
- 15927
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
16384.0
323.0
944
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
20.7
323.0
561
408
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
323.0
1593
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
3265.3
302.9
283
*
AA1AD
NOMESCO Finland
CT of head and brain
7.1
279.7
1014
3161
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
255.2
238
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
237.6
222
*
AA1AA
NOMESCO Finland
Head X-ray examination
90.9
236.2
260
34
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
205.8
193
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
626.9
173.8
169
*
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
167.7
158
*
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
19.7
160.7
250
149
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
131.1
124
*
AAF00
NOMESCO Finland
Ventriculostomy
161.0
127.4
133
9
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
118.2
112
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.2
108.7
325
635
P20
ICPC
Memory disturbance
3.8
107.0
567
2004
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
490.8
94.4
93
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.8
89.3
277
557
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
235.4
87.4
89
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
740.9
72.7
71
*
SPAT1053
SPAT
Memory test
2.9
71.4
568
2550
R42
ICD-10 Finland
Dizziness and giddiness
2.8
68.7
605
2881
SPAT1216
SPAT
Assessment of functional ability
2.9
66.3
506
2192
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.6
63.3
332
1095
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
5.8
61.5
186
355
L28
ICPC
Limited function/disability (L)
2.7
58.8
494
2243
SPAT1229
SPAT
Assessment of need for aid
3.5
57.6
305
1006
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.4
54.7
303
1031
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
54.4
201
478
R53
ICD-10 Finland
Malaise and fatigue
2.6
53.1
506
2442
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
50.7
443
2027
F03
ICD-10 Finland
Unspecified dementia
4.0
50.5
221
617
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.5
50.4
263
851
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
4.8
50.4
178
403
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
3.3
49.1
281
974
A28
ICPC
Limited function/disability NOS
2.5
47.8
490
2433
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
47.8
446
2106
N05AX08
ATC
risperidone; systemic
3.4
46.7
249
816
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
46.4
670
3923
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
45.5
482
2424
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.1
45.0
190
511
N99
ICPC
Neurological disease other
13.4
44.1
78
61
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
418.0
41.3
41
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.4
41.3
221
723
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.7
40.7
191
562
N05AH04
ATC
quetiapine; oral
2.8
40.1
295
1195
N06DX01
ATC
memantine; oral
2.9
39.7
271
1050
N06DA02
ATC
donepezil; oral
3.1
39.6
240
856
U04
ICPC
Incontinence urine
3.7
38.7
181
530
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
13.7
37.9
66
50
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
37.9
237
864
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
36.1
265
1069
SPAT1234
SPAT
Support of social functional capacity
3.4
35.7
188
605
TAB00
NOMESCO Finland
Lumbar puncture
5.4
35.5
110
214
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
35.3
579
3472
S06.0
ICD-10 Finland
Concussion
2.9
35.2
242
936
N03AG01
ATC
valproic acid; systemic, rectal
4.0
35.0
147
391
G04BD08
ATC
solifenacin; oral
3.0
34.1
213
774
G04BD07
ATC
tolterodine; oral
3.3
33.9
181
587
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
33.4
32
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.8
32.7
235
933
N02BE01
ATC
paracetamol; systemic, rectal
2.4
32.5
1394
11920
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.3
32.0
176
583
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
32.0
344
1696
SPAT1254
SPAT
Administration of medicine
2.2
31.1
359
1830
N28
ICPC
Limited function/disability (N)
6.8
30.7
79
121
N06AB10
ATC
escitalopram; oral
2.4
30.7
285
1304
G04BD12
ATC
mirabegron; oral
2.5
30.6
279
1263
N06AB04
ATC
citalopram; systemic
2.2
30.1
381
2020
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
29.3
28
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
29.1
338
1720
N06DA03
ATC
rivastigmine; oral, transdermal
3.2
29.0
162
541
G20
ICD-10 Finland
Parkinson disease
3.9
28.3
123
337
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.3
28.2
152
495
P70
ICPC
Dementia
4.4
28.0
106
256
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
27.2
26
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
6.3
27.0
73
120
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.1
26.8
109
281
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
+∞
26.1
25
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.2
25.6
140
461
M48.0
ICD-10 Finland
Spinal stenosis
2.2
25.0
303
1563
R51.80
ICD-10 Finland
Headache
2.4
24.6
220
980
SPAT1301
SPAT
No procedures
1.8
24.3
599
4018
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.2
24.0
277
1394
A04
ICPC
Weakness/tiredness general
2.1
23.9
291
1500
R1250
NOMESCO Finland
Evaluation of functional capability
5.9
23.6
67
118
N30.0
ICD-10 Finland
Acute cystitis
2.1
23.2
298
1571
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
3.2
23.1
130
436
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
23.1
124
403
N05AH03
ATC
olanzapine; systemic
3.7
22.7
104
298
F06.7
ICD-10 Finland
Mild cognitive disorder
3.6
22.7
106
309
SPAT1101
SPAT
Orthostatic test
2.8
22.4
150
564
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
6.5
21.7
57
91
K90
ICPC
Stroke/cerebrovascular accident
3.6
21.1
97
279
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
9.2
20.6
43
48
R41.0
ICD-10 Finland
Disorientation, unspecified
3.3
20.0
104
330
N29
ICPC
Neurological sympt/complt other
4.9
19.8
65
136
G04BD04
ATC
oxybutynin; oral, transdermal
2.6
19.7
155
641
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
19.5
105
342
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
19.1
618
4407
SPAT1252
SPAT
Overall medication plan or its review
2.3
19.0
182
835
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
18.9
159
681
WX320
NOMESCO Finland
Spinalanesthesy
0.5
18.8
142
2731
Z03
ICPC
Housing/neighbourhood problem
11.2
18.7
35
32
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
19.0
18.7
28
15
R32
ICD-10 Finland
Unspecified urinary incontinence
3.6
18.6
86
249
N06AX16
ATC
venlafaxine; oral
2.4
18.1
165
735
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
17.9
69
171
N06AX11
ATC
mirtazapine; oral
1.7
17.6
498
3402
A06AD11
ATC
lactulose; oral
1.8
17.4
345
2114
J01CA08
ATC
pivmecillinam; oral
1.6
17.4
597
4293
N05BA04
ATC
oxazepam; oral
1.7
17.0
409
2660
N05AB03
ATC
perphenazine; systemic, rectal
4.0
16.9
69
180
W19
ICD-10 Finland
Unspecified fall
2.1
16.9
197
985
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.6
16.8
77
222
N18
ICPC
Paralysis/weakness
4.1
16.6
66
168
G30.8
ICD-10 Finland
Other Alzheimer disease
3.3
16.6
84
262
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.5
16.5
78
231
R55
ICD-10 Finland
Syncope and collapse
1.9
16.2
245
1361
R26.0
ICD-10 Finland
Ataxic gait
21.2
16.0
23
11
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
3.1
15.8
90
304
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
5.0
15.7
50
102
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
15.6
15
*
N06AB06
ATC
sertraline; oral
2.4
15.5
141
629
WYA20
NOMESCO Finland
Home visit
3.9
15.4
63
165
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.1
15.4
60
151
N03AX09
ATC
lamotrigine; oral
4.6
15.2
52
115
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
9.3
15.2
31
34
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.6
15.2
44
81
ZXD05
NOMESCO Finland
Urgent procedure
1.6
15.1
503
3559
SPAT1251
SPAT
Organisation of medication
2.7
15.1
104
396
Z00.0
ICD-10 Finland
General medical examination
1.8
14.8
307
1898
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
14.8
258
1505
N04AA02
ATC
biperiden; systemic
5.2
14.6
45
89
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.8
14.6
48
102
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
14.5
91
330
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
14.5
214
3420
Z75.5
ICD-10 Finland
Holiday relief care
5.2
14.4
44
86
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
12.7
14.4
25
20
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
7.2
14.3
34
48
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.8
14.3
47
100
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.3
14.3
52
123
G04CA02
ATC
tamsulosin; oral
1.6
14.1
496
3546
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
13.9
288
1776
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
13.9
524
3805
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
20.2
13.8
20
10
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.1
13.7
162
816
L99
ICPC
Musculoskeletal disease other
4.2
13.5
51
125
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.0
13.5
189
1019
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.9
13.5
43
89
N03AB02
ATC
phenytoin; systemic
5.4
13.2
39
74
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
13.2
156
786
SPAT1042
SPAT
Guidance concerning balance maintenance
7.6
13.2
30
40
Z2445
NOMESCO Finland
Psychologist
4.1
13.0
50
125
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
12.9
287
1803
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.0
12.9
75
259
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
7.6
12.7
29
39
J01EA01
ATC
trimethoprim; systemic
1.6
12.6
440
3125
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.5
487
3545
2132
FHL
Ventricular operators sunt
131.0
12.4
13
*
N03AX14
ATC
levetiracetam; systemic
3.6
12.3
55
157
N05AX12
ATC
aripiprazole; systemic
5.0
12.2
38
77
A29
ICPC
General symptom/complaint other
1.8
12.1
215
1260
SPAT1262
SPAT
Handing over of treatment supplies
1.6
12.1
329
2190
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.6
12.0
30
46
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
12.0
210
3240
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
3.9
12.0
48
125
G04BD09
ATC
trospium; oral
2.8
11.8
75
276
188
Kela drug reimbursment
Psychosis requiring demanding treatment
9.7
11.7
23
24
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.0
11.7
164
884
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
3.2
11.6
60
193
SPAT1304
SPAT
Counselling and guidance related to ageing
1.9
11.5
179
1001
AXX01
SPAT
NA
4.0
11.5
45
115
2133
FHL
Suntin revisio
+∞
11.5
11
*
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
11.5
11
*
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
11.5
11
*
N06AB03
ATC
fluoxetine; oral
1.9
11.5
169
928
N87
ICPC
Parkinsonism
3.7
11.4
48
131
F05.9
ICD-10 Finland
Delirium, unspecified
3.3
11.4
57
179
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.5
11.2
51
149
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
11.2
11.0
20
18
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.2
11.0
108
500
T90.5
ICD-10 Finland
Sequelae of intracranial injury
6.9
10.9
26
38
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.7
10.7
72
275
N05AC02
ATC
thioridazine; oral
4.6
10.7
36
80
N05AA02
ATC
levomepromazine; systemic
2.8
10.6
66
238
N05BA01
ATC
diazepam; systemic, rectal
1.7
10.6
222
1369
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
10.6
581
4515
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
10.6
217
1331
N05AH02
ATC
clozapine; systemic
7.5
10.2
23
31
SPAT1139
SPAT
Nutrition survey
2.6
10.1
71
276
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
10.1
137
729
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.5
10.1
34
76
183
Kela drug reimbursment
Lamotrigin and topiramate
11.4
10.1
18
16
R27.0
ICD-10 Finland
Ataxia, unspecified
8.5
10.1
21
25
SPAT1167
SPAT
Insertion of urinary catheter
2.3
10.0
89
395
SPAT1307
SPAT
Psychosocial counselling and guidance
3.1
9.9
53
175
R26
ICD-10 Finland
Abnormalities of gait and mobility
7.7
9.9
22
29
S01.0
ICD-10 Finland
Open wound of scalp
2.0
9.8
135
721
N80
ICPC
Head injury other
3.7
9.8
41
112
N05AF03
ATC
chlorprothixene; systemic
3.9
9.8
39
102
S72.0
ICD-10 Finland
Fracture of neck of femur
2.1
9.7
107
523
Z11
ICPC
Compliance/being ill problem
6.6
9.7
24
37
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.2
9.7
50
161
ZXA00
NOMESCO Finland
Right side
1.5
9.7
469
3541
N03AF01
ATC
carbamazepine; oral, rectal
2.3
9.7
92
420
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.6
9.7
151
2409
130
Kela drug reimbursment
Malignant tumour
0.4
9.5
40
958
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.5
636
5106
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.4
9.5
45
137
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
9.4
492
3767
2124
FHL
Intracranial pressure measurement, intraventricular
+∞
9.4
9
*
T85.7
ICD-10 Finland
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
21.8
9.4
13
6
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
9.6
9.3
18
19
J01DB01
ATC
cefalexin; oral
1.4
9.2
1150
10283
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
9.0
245
1620
Z2221
NOMESCO Finland
Medical doctor
0.6
9.0
210
3066
SPAT1279
SPAT
Preparation of immediate hospitalisation
3.6
8.9
38
106
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.6
8.9
38
106
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
7.5
8.9
20
27
G30.0
ICD-10 Finland
Alzheimer disease with early onset
4.4
8.9
31
72
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.1
8.9
101
503
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.0
8.9
105
530
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
8.8
168
1003
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
10.8
8.8
16
15
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.4
8.8
22
35
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.3
8.8
82
375
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.7
8.7
28
60
G04BD11
ATC
fesoterodine; oral
2.4
8.7
72
309
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.1
8.7
32
79
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
8.6
80
362
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
0.5
8.5
51
1075
N30.9
ICD-10 Finland
Cystitis, unspecified
2.0
8.5
109
570
AAA10
NOMESCO Finland
Biopsy through craniotomy
20.1
8.5
12
6
L29
ICPC
Musculoskeletal sympt/complt other
1.9
8.4
122
664
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.7
8.4
27
58
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
8.4
104
536
N06AX21
ATC
duloxetine; oral
1.9
8.4
131
733
G91
ICD-10 Finland
Hydrocephalus
+∞
8.3
8
*
N06AX03
ATC
mianserin; oral
2.2
8.3
81
377
N05AN01
ATC
lithium; oral
3.6
8.3
35
98
N17
ICPC
Vertigo/dizziness
1.6
8.2
202
1299
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
6.5
8.2
20
31
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
8.1
147
865
N06DA04
ATC
galantamine; oral
2.6
8.1
59
236
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
8.0
256
1758
K91
ICPC
Cerebrovascular disease
3.4
8.0
37
111
R11
ICD-10 Finland
Nausea and vomiting
1.8
8.0
128
721
F22.0
ICD-10 Finland
Delusional disorder
3.7
8.0
33
91
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.6
8.0
55
215
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
5.0
7.9
24
49
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
7.9
120
668
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.5
7.9
26
58
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.9
247
1689
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.9
7.8
45
157
N06AX26
ATC
vortioxetine; oral
2.5
7.7
60
249
SPAT1244
SPAT
Occupational therapy
4.3
7.7
27
64
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
45.2
7.7
9
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
7.7
53
207
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.8
7.6
24
51
359
Kela drug reimbursment
Mirabegroni
4.5
7.6
25
56
S06.3
ICD-10 Finland
Focal brain injury
3.7
7.6
31
85
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.5
221
1489
XF402
NOMESCO Finland
ECG with work load test
0.5
7.4
72
1306
G41.2
ICD-10 Finland
Complex partial status epilepticus
13.4
7.4
12
9
A10BH01
ATC
sitagliptin; oral
1.6
7.4
171
1085
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
7.3
1166
10595
Z08
ICPC
Social welfare problem
4.2
7.3
26
63
G04BD10
ATC
darifenacin; oral
4.2
7.3
26
63
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.9
7.3
42
147
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.7
7.2
47
178
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.4
7.2
33
99
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
15.8
7.2
11
7
G21.8
ICD-10 Finland
Other secondary parkinsonism
15.8
7.2
11
7
SPAT1014
SPAT
Treatment of eyes
2.8
7.2
43
155
N03AF02
ATC
oxcarbazepine; oral
2.7
7.2
47
179
ZYC01
SPAT
NA
2.3
7.2
65
292
SPAT1263
SPAT
Sampling
1.3
7.1
621
5135
G72.8
ICD-10 Finland
Other specified myopathies
3.1
7.1
37
123
R50.9
ICD-10 Finland
Fever, unspecified
1.6
7.1
201
1342
-
ICD-10 Finland
NA
2.7
7.1
46
175
SPAT1050
SPAT
Extensive neurological examination
2.6
7.1
49
192
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
7.0
191
2717
E0000UV
ATC
NA
1.4
7.0
524
4227
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
6.9
62
280
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.5
6.8
29
83
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.2
6.8
65
301
SPAT1153
SPAT
Removal of sutures
1.4
6.7
488
3912
S82
ICPC
Naevus/mole
0.5
6.7
55
1049
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
22.6
6.7
9
*
A10BA02
ATC
metformin; oral
1.4
6.7
480
3845
F01.9
ICD-10 Finland
Vascular dementia, unspecified
2.7
6.7
41
152
R21
ICPC
Throat symptom/complaint
0.5
6.6
62
1138
Z60.8
ICD-10 Finland
Other problems related to social environment
7.8
6.6
14
18
WW200
SPAT
NA
1.8
6.6
111
641
T90
ICPC
Diabetes non-insulin dependent
1.4
6.5
383
2961
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
3.2
6.5
31
97
XJH00
NOMESCO Finland
Transanal ultrasonography
1.7
6.5
127
765
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
6.5
122
727
R33
ICD-10 Finland
Retention of urine
1.6
6.5
159
1022
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.1
6.5
32
103
G41.9
ICD-10 Finland
Status epilepticus, unspecified
6.2
6.5
16
26
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.8
6.5
39
143
R60.0
ICD-10 Finland
Localized oedema
1.5
6.4
194
1312
2139
FHL
Other measure in this category
70.1
6.4
7
*
2130
FHL
Ventricular atrial shunt
70.1
6.4
7
*
S70.0
ICD-10 Finland
Contusion of hip
2.0
6.4
74
373
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.4
6.4
52
225
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.4
459
3670
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.1
6.4
67
325
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
6.3
94
520
C03CA01
ATC
furosemide; systemic
1.3
6.3
627
5260
P72
ICPC
Schizophrenia
4.2
6.3
22
53
F0019, G301
ICD-10 Finland
NA
3.2
6.3
30
94
Y96.9
ICD-10 Finland
Unspecified type of accident
3.2
6.3
30
94
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.3
555
4576
F31
ICD-10 Finland
Bipolar affective disorder
6.0
6.3
16
27
G90.2
ICD-10 Finland
Horner syndrome
9.3
6.3
12
13
M54.5
ICD-10 Finland
Low back pain
1.4
6.3
394
3080
P29
ICPC
Psychological sympt/compl other
2.4
6.3
48
201
DJA10
NOMESCO Finland
Biopsy of septum of nose
26.8
6.2
8
*
R41.3
ICD-10 Finland
Other amnesia
2.1
6.2
66
321
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.3
6.2
54
242
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
6.2
54
243
H25.8
ICD-10 Finland
Other senile cataract
0.6
6.2
116
1780
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.1
301
2255
N03AX18
ATC
lacosamide; systemic
7.7
6.1
13
17
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
6.1
149
959
A10AE04
ATC
insulin glargine; parenteral
1.6
6.1
150
968
ZXC86
NOMESCO Finland
Use of endoscopic device
6.7
6.0
14
21
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.5
6.0
44
181
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
589
220
40.17
307.65
1.9
1.2
e6/l
6.9
55.1
1.00
512
163
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
442
241
24.33
307.65
1.9
1.1
mmol/l
3.9
4.0
0.20
432
218
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
591
220
40.38
307.65
1.9
1.2
e6/l
1530.9
972.9
0.21
529
172
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
330
86
47.23
307.65
1.1
1.0
ng/l
249.6
356.5
1.67
95
56
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
610
262
35.51
307.65
1.8
1.1
mg/l
379.7
598.2
6.95
604
240
(3044290) Cell count panel - Cerebral spinal fluid
370
206
22.60
307.65
1.5
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
315
104
36.85
307.65
1.5
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
330
86
47.23
307.65
1.1
1.0
ng/l
31.5
50.2
2.48
91
54
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
330
86
47.23
307.65
1.1
1.0
ng/l
545.5
605.0
0.62
94
54
(3016018) Differential panel - Cerebral spinal fluid
215
97
25.18
298.33
1.5
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
171
56
33.79
264.75
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
169
98
19.01
209.22
1.4
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
98
49
21.15
129.00
1.6
1.1
%
44.4
65.7
—
5
7
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
83
31
28.08
122.13
1.5
1.1
%
14.1
16.4
—
12
5
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
66
19
36.08
105.08
1.2
1.2
%
29.6
61.8
—
30
5
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
502
1985
3.16
93.66
9.1
8.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
389
1366
3.39
87.89
4.0
3.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
611
3079
2.53
68.24
6.6
4.8
kg/l
1.0
1.0
0.17
49
503
(3011397) Hemoglobin [Presence] in Urine by Test strip
646
3365
2.47
66.90
5.9
4.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
676
3799
2.28
56.80
6.3
4.7
estimate
0.0
0.0
0.50
129
1227
(3009466) Valproate [Moles/volume] in Serum or Plasma
92
165
5.83
49.39
5.0
3.6
umol/l
392.4
344.0
2.00
81
139
(3018405) Lactate [Moles/volume] in Arterial blood
182
638
3.07
39.54
3.1
3.5
mmol/l
1.5
1.4
0.36
182
625
(3020891) Body temperature
194
719
2.91
38.13
3.5
4.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
614
3773
1.98
37.13
1.8
1.8
nmol/l
1433.4
1177.3
10.06
500
2763
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
723
4821
1.86
33.17
2.6
2.2
u/l
276.2
247.7
0.23
663
4479
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
763
5192
1.84
32.65
6.4
4.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
579
3670
1.87
30.63
3.1
4.0
%
88.0
82.7
6.01
548
3580
(3026008) Bacteria identified in Urine by Culture
784
5484
1.79
29.77
4.3
3.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
918
6824
1.74
27.35
6.0
4.3
estimate
0.0
0.0
0.00
139
1303
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
310
1692
2.01
24.98
2.6
2.5
ug/l
4.6
6.2
1.59
261
1426
(3009261) Glucose [Presence] in Urine by Test strip
916
6922
1.69
24.67
6.0
4.3
estimate
0.0
0.0
0.50
130
1273
(3014007) Fractional oxyhemoglobin in Arterial blood
218
1053
2.23
24.15
3.7
8.1
%
93.9
93.9
0.03
218
1046
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
219
1060
2.22
24.14
3.7
8.0
%
0.8
0.7
2.52
219
1053
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
790
5764
1.68
24.11
3.7
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
510
3305
1.77
23.94
2.6
3.1
mmol/l
2.5
2.5
0.99
449
2887
(3021601) Nitrite [Presence] in Urine by Test strip
900
6826
1.67
23.43
7.1
5.8
estimate
0.0
0.0
0.00
135
1289
(3008152) Bicarbonate [Moles/volume] in Arterial blood
228
1138
2.16
23.23
5.9
6.1
mmol/l
24.7
24.5
0.23
218
1057
(3031040) Bacteria [#/volume] in Urine by Automated count
1209
9936
1.73
22.95
7.0
5.4
e6/l
1601.0
1808.8
0.08
22
173
(4034850)
114
424
2.81
22.07
12.5
11.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
845
6394
1.63
21.50
4.4
4.4
ng/l
52.0
71.0
0.53
694
5065
(3019060) Gas panel - Arterial blood
228
1216
2.01
19.30
3.7
4.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
202
1055
2.04
18.09
1.6
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1083
8946
1.57
17.28
4.8
4.8
mmol/l
7.1
6.9
1.77
1046
8447
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
516
3634
1.60
16.52
1.8
1.8
pmol/l
469.3
11253451.9
1.51
439
2897
(3002173) Hemoglobin [Mass/volume] in Arterial blood
274
1638
1.80
16.21
4.0
7.0
g/l
124.8
119.7
4.00
266
1568
(3014576) Chloride [Moles/volume] in Serum or Plasma
339
2167
1.70
15.82
3.7
6.2
mmol/l
104.5
104.1
0.66
333
2110
(1761868) Lipid panel - Serum or Plasma
187
3226
0.53
15.17
3.4
3.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
291
1809
1.73
14.97
3.9
6.6
%
95.9
95.4
0.90
285
1727
(40768804) Tissue Pathology biopsy report
384
5426
0.62
14.47
2.1
2.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
16
16
10.08
14.03
12.3
17.2
nmol/l
1068.1
1708.2
0.99
16
16
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
315
2035
1.67
13.98
3.8
6.3
kpa
5.0
5.1
0.32
308
1914
(3027801) Oxygen [Partial pressure] in Arterial blood
314
2036
1.66
13.72
3.8
6.3
kpa
12.6
11.6
1.90
306
1917
(42870588) Differential panel, method unspecified - Blood
338
4863
0.62
13.55
4.5
5.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
197
1128
1.84
13.31
2.0
3.2
ml/min/173m2
59.5
56.7
0.47
67
513
(3023368) Bacteria identified in Blood by Culture
647
4970
1.48
13.26
4.4
4.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
694
5449
1.46
12.51
2.4
3.4
mmol/l
2.4
2.4
0.40
595
4594
(3003396) Base excess in Arterial blood by calculation
308
2035
1.63
12.39
3.9
6.3
mmol/l
1.5
1.2
0.62
239
1562
(3002030) Lymphocytes/100 leukocytes in Blood
503
6524
0.68
11.84
5.2
5.8
%
26.3
25.3
1.18
442
5976
(3006504) Eosinophils/100 leukocytes in Blood
492
6397
0.68
11.68
5.1
5.6
%
2.9
2.8
0.16
439
5887
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
315
2122
1.59
11.64
1.8
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
493
6404
0.68
11.63
5.2
5.6
%
58.0
59.2
1.29
438
5907
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
220
3404
0.59
11.59
1.5
1.6
mmol/l
1.4
1.3
1.05
189
2782
(3019069) Monocytes/100 leukocytes in Blood
496
6420
0.68
11.41
5.3
5.9
%
9.1
9.0
0.14
441
5927
(3044640) Blood type and Crossmatch panel - Blood
614
4779
1.44
11.29
2.3
2.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
849
7009
1.42
11.23
3.8
4.6
g/l
34.9
34.3
2.35
780
6440
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
490
3663
1.47
11.10
2.1
2.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
973
11162
0.71
11.07
20.2
20.3
%
38.6
37.6
1.94
458
6492
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1082
12179
0.70
10.94
17.5
17.8
ml/min/173m2
71.7
69.8
2.41
925
10109
(3022096) Basophils/100 leukocytes in Blood
483
6241
0.69
10.83
5.1
5.6
%
0.7
0.6
0.33
430
5753
(3002385) Erythrocyte distribution width [Ratio]
888
10292
0.72
10.30
22.7
22.5
%
14.0
14.0
0.15
862
10022
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
64
4.11
9.71
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
306
2140
1.52
9.43
1.8
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
799
6690
1.36
8.93
4.1
4.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
73
3.74
8.90
1.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
830
6997
1.36
8.85
6.9
11.5
inr
1.3
1.4
3.19
175
1859
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
40
4.79
8.59
1.1
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
20
6.54
8.07
1.1
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
43
4.46
7.90
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
21
6.23
7.71
1.1
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
40
4.54
7.65
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
40
4.54
7.65
1.1
1.1
—
—
—
0
0
(3013512) EKG study
369
4771
0.71
7.56
4.6
4.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
112
1862
0.57
7.52
3.6
4.1
ug/l
5.1
26.2
2.96
90
1559
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
86
455
1.94
7.45
2.1
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
852
7343
1.32
7.26
4.8
5.9
mmol/l
1.2
1.2
4.99
774
6549
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
43
4.22
7.01
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1085
11911
0.76
6.76
3.9
4.2
mmol/l
1.4
1.3
5.70
952
10400
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
40
4.28
6.75
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
90
3.03
6.51
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
47
966
0.47
6.26
1.3
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
82
3.08
6.20
1.3
2.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1122
10162
1.30
6.08
26.8
25.0
g/l
331.0
330.6
0.79
1089
10036
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
123
1897
0.62
6.07
5.2
4.8
%
32.4
33.8
0.73
80
1191
(3002256) Pathology report gross observation
119
1838
0.62
5.91
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
125
1906
0.63
5.87
1.2
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
331
2551
1.37
5.84
1.6
1.9
s
28.8
30.1
4.77
326
2462
(3022145) Colonoscopy Study observation
90
1474
0.59
5.68
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
386
3060
1.34
5.65
1.8
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1137
12299
0.78
5.53
4.2
4.7
mmol/l
1.4
1.4
4.35
1017
10866
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
21
5.27
5.52
1.4
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
130
846
1.58
5.50
2.0
2.4
%
0.7
0.6
1.69
123
811
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1154
12448
0.78
5.39
4.3
4.8
mmol/l
4.3
4.4
2.05
1039
11101
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
63
1113
0.55
5.26
1.6
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1199
12857
0.78
5.22
4.9
5.5
mmol/l
2.5
2.5
1.02
1075
11410
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
793
6986
1.25
4.93
2.2
2.2
pmol/l
92.6
92.5
0.03
432
3542
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
62
3.09
4.79
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
423
3478
1.29
4.65
2.9
2.7
e6/l
5.2
4.9
0.19
379
3063
(3000330) Specific gravity of Urine by Test strip
51
923
0.54
4.65
6.1
4.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
11
25
4.42
4.56
2.4
2.2
umol/l
38.5
40.0
0.07
11
20
(21494755) Public health laboratory ask at order entry panel
6
244
0.24
4.49
1.0
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
121
1744
0.67
4.34
2.4
3.1
ng/l
171.7
253.8
2.12
106
1596
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
31
637
0.48
4.21
1.7
3.1
u/ml
18.3
6548.0
0.87
24
542
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
127
1794
0.68
4.10
1.2
1.2
u/ml
16.4
15.8
0.03
51
579
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
331
4038
0.78
4.09
2.6
3.1
u/l
29.9
36.0
2.73
307
3814
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
91
590
1.57
3.98
1.4
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
14
6.46
3.98
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
359
0.33
3.97
1.5
1.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
211
0.23
3.96
8.0
4.0
u/ml
48.0
38.5
—
5
205
(3004789) Transferrin [Mass/volume] in Serum or Plasma
189
2479
0.73
3.93
2.3
2.5
g/l
2.3
2.3
0.00
168
2260
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
224
0.27
3.92
1.3
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
322
2619
1.28
3.80
22.8
32.1
inr
1.5
1.5
0.11
26
344
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
179
2355
0.73
3.80
2.4
2.6
%
19.7
21.4
1.20
147
1972
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
76
1173
0.63
3.79
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
222
0.27
3.77
1.3
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
116
1639
0.69
3.76
2.4
2.6
umol/l
10.9
9.9
0.10
92
1430
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
21
84
2.52
3.72
2.5
1.6
u/field
0.7
3.4
2.51
13
57
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
889
8092
1.20
3.58
5.3
6.7
mmol/l
1.2
1.2
2.92
771
6766
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
139
1880
0.72
3.51
1.3
1.2
iu/ml
59.3
39.9
0.49
43
600
(3007164) IgA [Mass/volume] in Serum or Plasma
164
2157
0.74
3.47
1.4
1.5
g/l
2.8
2.8
0.12
90
1210
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1170
12401
0.82
3.41
6.9
6.9
mmol/mol
42.8
41.3
5.02
1077
11154
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1214
12819
0.82
3.38
5.0
5.2
mmol/l
6.3
6.1
2.05
1085
11260
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
14
5.74
3.34
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
65
2.63
3.30
1.1
1.1
nmol/l
146.8
133.5
0.41
17
65
(3014271) Vancomycin [Susceptibility]
27
128
2.13
3.30
3.3
3.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1381
13169
1.25
3.27
20.8
18.4
mg/l
28.1
27.9
0.05
1218
10943
(3021589) Normoblasts [#/volume] in Blood
515
5867
0.83
3.27
10.3
10.6
e9/l
0.0
0.0
0.03
428
4736
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
43
3.04
3.25
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1057
9838
1.19
3.13
3.9
3.9
pmol/l
15.8
15.2
10.71
942
8601
(3007853) Bacteria identified in Skin by Aerobe culture
218
1731
1.30
3.10
1.7
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
622
0.55
3.09
1.1
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
50
2.81
3.09
1.0
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
271
3283
0.79
3.08
3.7
4.2
ng/l
415.0
308.8
0.26
226
2906
(3022621) pH of Urine by Test strip
73
1083
0.66
3.07
3.9
3.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
96
1347
0.70
3.02
2.6
2.3
u/l
30.8
35.8
1.07
80
1116
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
12
5.85
3.02
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
492
4291
1.21
3.01
1.7
1.6
nmol/l
20.0
20.1
0.03
440
3579
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
82
2.33
2.91
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
184
1441
1.31
2.90
2.5
2.9
kpa
4.3
4.4
0.42
175
1390
(3013115) Eosinophils [#/volume] in Blood
630
6991
0.84
2.88
5.2
5.4
e9/l
0.2
0.2
0.98
544
5997
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
18
4.46
2.79
1.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
329
3855
0.82
2.71
2.5
2.9
umol/l
2051.9
7292.1
3.24
266
3217
(3048689) Calprotectin [Mass/mass] in Stool
89
1239
0.70
2.70
1.8
1.9
ug/g
143.3
158.0
0.26
67
954
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
268
3206
0.81
2.70
2.7
3.4
ug/l
0.7
0.8
1.86
189
2334
(3037522) Nuclear Ab [Titer] in Serum
108
1452
0.73
2.66
1.2
1.3
titre
960.0
546.8
0.81
21
337
(3022948) Iron [Moles/volume] in Serum or Plasma
220
2683
0.79
2.63
2.2
2.5
umol/l
10.9
11.8
1.27
198
2453
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
38
2.91
2.58
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
20
4.01
2.57
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
117
874
1.36
2.57
1.7
1.6
%
1.6
1.6
0.31
98
707
(3000991) Gas panel - Venous blood
178
1419
1.28
2.48
3.4
7.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
57
2.47
2.45
2.9
2.1
umol/l
58.8
53.5
—
9
39
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
16
337
0.47
2.45
1.3
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
188
1514
1.27
2.42
3.0
6.0
mmol/l
1.6
1.4
1.21
178
1452
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
163
2037
0.78
2.40
2.8
3.8
u/l
235.1
251.6
0.75
147
1905
(3041096) Erythrocytes [Presence] in Urine by Automated
298
3486
0.82
2.40
4.9
4.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
777
0.66
2.32
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
369
3204
1.19
2.32
1.3
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
615
6747
0.86
2.28
4.8
5.2
e9/l
0.6
0.6
0.07
526
5686
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
259
0.42
2.27
1.1
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
635
5773
1.16
2.26
2.6
3.3
ng/l
1135.0
1890.2
6.91
542
5040
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
328
2825
1.20
2.25
3.0
3.0
e6/l
2.0
1.3
0.84
210
1664
(3018095) Leukocytes [#/volume] in Urine
610
5530
1.16
2.25
4.4
4.0
e6/l
168.4
132.5
0.19
462
4093
(3000764) Benzodiazepines [Presence] in Urine
15
66
2.28
2.24
1.0
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
619
6779
0.86
2.22
4.9
5.3
e9/l
0.0
0.0
0.35
530
5737
(3028707) Methadone [Presence] in Urine by Screen method
10
36
2.79
2.20
1.0
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
24
3.34
2.18
1.0
1.1
miu/ml
2170.8
1634.1
—
8
24
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
195
0.41
2.17
2.5
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
638
5818
1.15
2.16
2.3
2.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
15
306
0.49
2.13
1.2
1.1
—
84.0
—
0
20
(3014051) Protein [Presence] in Urine by Test strip
20
371
0.53
2.13
2.7
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
503
4513
1.16
2.11
3.6
3.4
e6/l
0.6
0.5
0.01
407
3490
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
49
2.46
2.10
1.3
1.1
u/l
1.2
1.3
—
7
28
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
342
0.52
2.07
1.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
633
6896
0.87
2.07
5.1
5.4
e9/l
1.9
1.9
0.01
535
5938
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
404
0.56
2.04
1.6
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
479
4294
1.16
2.03
3.6
3.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
514
5675
0.87
2.02
2.5
2.9
ug/l
136.0
155.4
1.31
458
5073
(3022313) Gas panel - Capillary blood
56
800
0.69
2.02
4.8
3.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
117
1490
0.77
2.02
1.7
2.0
g/l
0.2
0.2
0.18
101
1375
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
39
247
1.59
2.02
1.7
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
232
0.43
2.02
1.3
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
57
2.29
1.98
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
514
4640
1.15
1.97
2.3
2.4
u/l
61.4
58.4
0.23
471
4231
(3016879) Cocaine [Presence] in Urine
14
64
2.20
1.94
1.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
11
4.56
1.94
1.2
1.8
umol/l
18.1
15.4
—
5
11
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
43
640
0.66
1.93
2.1
2.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
187
0.43
1.93
2.6
3.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
39
2.57
1.92
1.1
2.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
253
0.47
1.90
1.5
1.4
e6/l
24579.9
80215.9
—
7
150
(3034770) Mitochondria Ab [Titer] in Serum
17
318
0.53
1.89
1.2
1.1
—
746.3
—
0
8
(4015189)
0
52
0.00
1.88
0.0
2.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
67
912
0.72
1.85
1.4
1.7
g/l
1.6
1.5
0.26
57
777
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
82
1082
0.75
1.85
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
196
0.46
1.84
2.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
198
0.45
1.84
2.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1330
13735
0.86
1.84
10.0
11.5
u/l
23.7
23.8
0.06
1262
13080
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
59
2.21
1.84
1.1
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
199
0.45
1.84
2.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
531
4826
1.15
1.83
3.3
4.0
ph
7.4
7.4
0.23
85
899
(4010399)
77
1024
0.74
1.83
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1375
13303
1.17
1.82
18.2
17.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
66
2.13
1.82
1.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
66
2.13
1.82
1.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
66
2.13
1.82
1.0
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
53
2.27
1.80
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
34
523
0.64
1.80
7.4
5.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
166
0.42
1.79
1.7
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
374
0.58
1.77
1.5
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
742
7939
0.89
1.75
7.8
8.4
e9/l
4.5
4.4
1.09
647
6843
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
194
0.46
1.72
2.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
195
0.46
1.72
2.3
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
48
0.00
1.69
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
164
0.42
1.66
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
63
848
0.73
1.65
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
960
0.75
1.64
1.2
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
94
1194
0.77
1.63
6.4
4.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
474
0.65
1.62
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1024
9751
1.12
1.60
4.6
4.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
63
2.07
1.60
1.1
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
81
622
1.32
1.58
2.1
2.1
ug/l
735.0
838.1
0.09
73
582
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
110
1363
0.79
1.57
2.5
3.6
ng/l
76.2
99.6
3.11
91
1139
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
348
0.60
1.56
1.4
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
46
323
1.44
1.54
1.7
2.5
umol/l
28.3
33.6
1.22
34
258
(40768800) Prostate Pathology biopsy report
23
371
0.61
1.54
1.2
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
2.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
43
0.00
1.52
0.0
1.3
—
53.5
—
0
15
(3038515) Glucose [Moles/volume] in Venous blood
29
442
0.65
1.51
4.9
3.6
mmol/l
7.0
7.9
1.81
29
433
(3028026) IgM [Mass/volume] in Serum or Plasma
60
801
0.74
1.51
2.2
1.7
g/l
1.3
1.5
0.58
49
710
(3045788) Cell count panel - Pleural fluid
11
218
0.50
1.51
1.7
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
48
662
0.72
1.48
5.5
4.0
mmol/l
25.3
24.9
0.37
42
603
(3021440) Promyelocytes/100 leukocytes in Blood
94
1178
0.79
1.48
3.1
3.9
%
0.7
0.1
0.65
15
365
(3004616) Nuclear Ab [Presence] in Serum
8
167
0.48
1.47
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
169
0.47
1.46
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
329
0.60
1.46
1.9
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
202
0.49
1.46
1.5
4.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
132
1589
0.82
1.45
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
244
1.49
1.45
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
47
646
0.72
1.43
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
89
1114
0.79
1.40
3.1
3.8
%
1.3
0.6
—
9
275
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
79
1003
0.78
1.40
1.3
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
138
0.43
1.40
1.0
1.2
—
60.7
—
0
8
(40768795) Lymph node Pathology biopsy report
5
122
0.41
1.37
1.6
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
26
167
1.57
1.34
1.9
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
247
0.56
1.34
2.4
2.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
37
0.00
1.34
0.0
1.3
—
72.9
—
0
27
(4094501)
20
321
0.62
1.34
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
333
0.63
1.34
2.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
39
0.00
1.33
0.0
6.7
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
40
0.00
1.32
0.0
1.1
—
285.1
—
0
27
(3044927) Protein electrophoresis panel - Urine
12
220
0.54
1.32
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
149
0.47
1.31
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
149
0.47
1.31
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
149
0.47
1.31
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
41
0.00
1.31
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
18
2.78
1.28
1.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
6
132
0.45
1.28
1.0
1.3
—
—
—
0
0
(3036489) Thrombin time
60
457
1.32
1.28
1.5
1.9
s
20.2
21.8
1.18
54
414
(3012441) Differential panel - Pleural fluid
13
230
0.56
1.27
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1035
9932
1.11
1.26
5.8
4.9
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
19
303
0.62
1.25
1.5
2.3
%
201.4
211.8
0.26
19
286
(3003181) Sodium [Moles/volume] in Urine
48
355
1.36
1.24
1.6
1.3
mmol/l
71.6
59.7
1.33
42
285
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
25
2.40
1.24
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
277
0.61
1.23
1.2
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
196
2239
0.86
1.22
1.9
2.3
%
1.8
1.8
0.21
161
1946
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
90
1104
0.81
1.22
4.4
3.8
kpa
5.2
5.2
0.12
81
1007
(3019832) Treponema pallidum Ab [Presence] in Serum
43
315
1.37
1.19
1.2
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
197
1722
1.16
1.19
2.8
3.5
kpa
5.8
5.8
0.13
187
1665
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
212
2400
0.87
1.17
1.2
1.2
u/ml
1.0
1.5
0.92
71
573
(3009343) pH of Capillary blood
89
1087
0.81
1.17
4.5
3.8
ph
7.4
7.4
0.55
14
133
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
35
0.00
1.15
0.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
87
1.73
1.15
1.2
1.9
—
—
—
0
0
(4035726)
107
1280
0.83
1.15
1.2
1.4
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
36
0.00
1.14
0.0
2.8
—
14.6
—
0
31
(3017732) Neutrophils [#/volume] in Blood
68
853
0.79
1.13
2.9
3.3
e9/l
4.1
4.2
0.25
46
581
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
149
1279
1.18
1.13
1.8
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
81
995
0.80
1.13
2.6
2.8
g/l
10.3
10.8
0.48
73
892
(3025159) Blasts/100 leukocytes in Blood
90
1093
0.81
1.12
3.1
3.9
%
0.2
0.4
0.17
13
303
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
490
4560
1.10
1.09
4.4
4.9
%
21.3
22.0
0.53
254
2452
(3017181) Myelocytes/100 leukocytes in Blood
105
1250
0.83
1.08
3.0
3.9
%
3.5
0.9
1.10
23
399
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
20
303
0.66
1.08
1.1
1.2
—
62.9
—
0
7
(3000285) Sodium [Moles/volume] in Blood
7
32
2.19
1.08
1.1
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
34
466
0.72
1.07
4.5
3.5
mmol/l
1.7
1.7
0.06
34
458
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
161
1.50
1.07
1.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
36
487
0.73
1.05
4.0
3.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
15
90
1.67
1.04
1.7
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
285
2582
1.12
1.03
4.7
4.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
203
0.59
1.03
1.9
1.7
nmol/l
48.0
47.1
0.03
12
189
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
74
907
0.81
1.03
2.6
2.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
177
0.56
1.02
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
106
0.47
1.01
1.4
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
53
413
1.29
1.01
1.8
2.4
ug/min
161.0
86.7
0.48
23
240
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
132
0.53
0.99
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
30
0.00
0.97
0.0
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
100
1.61
0.96
1.8
4.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
193
1715
1.14
0.96
2.8
3.5
mmol/l
2.5
2.0
1.15
150
1356
(3040151) Glucose [Moles/volume] in Capillary blood
30
216
1.40
0.95
5.5
6.0
mmol/l
8.5
7.6
0.32
21
184
(44806118)
24
166
1.45
0.94
1.3
1.5
—
—
—
0
0
(44790049)
24
166
1.45
0.94
1.3
1.5
—
—
—
0
0
(44790047)
24
166
1.45
0.94
1.3
1.5
—
—
—
0
0
(44790048)
24
166
1.45
0.94
1.3
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
655
0.79
0.93
3.6
3.3
mg/l
56.0
150.8
0.55
44
527
(3008898) HLA-B27 [Presence]
14
221
0.63
0.93
1.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
28
385
0.72
0.93
1.1
1.3
—
27.0
—
0
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
654
0.79
0.92
3.5
3.3
mg/l
32.6
83.2
1.47
45
529
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
1046
0.83
0.92
4.4
3.7
mmol/l
2.0
2.1
0.09
62
766
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
220
0.63
0.92
1.3
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
26
184
1.42
0.91
2.2
2.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
29
2.07
0.89
1.0
1.2
g/l
0.3
0.3
—
6
23
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
63
770
0.81
0.88
1.8
2.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
181
0.61
0.88
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
130
0.54
0.88
1.1
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
51
637
0.79
0.87
3.5
3.3
ratio
2.0
1.9
—
7
45
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
44
1.82
0.86
1.1
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
717
7491
0.93
0.84
2.9
3.2
u/l
47.6
56.6
2.03
645
6715
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
203
0.64
0.84
1.2
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
273
0.69
0.83
3.5
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
476
5045
0.92
0.80
3.7
4.0
mg/mmol
12.4
8.9
0.63
348
3193
(21494434) Karyotype in Bone marrow
11
176
0.62
0.80
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
31
233
1.34
0.79
1.5
1.3
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
24
0.00
0.79
0.0
1.3
—
6.8
—
0
13
(3020874) Milk IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
0.4
—
0
10
(3014891) Appearance of Pleural fluid
6
33
1.82
0.79
1.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
151
1695
0.88
0.78
4.1
4.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
123
0.57
0.78
1.4
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
165
1.40
0.78
2.4
2.1
u/field
3.5
1.7
0.51
11
48
(3042936) Bacteria identified in Isolate by Culture
245
2242
1.11
0.77
1.7
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
44
549
0.80
0.76
3.1
3.3
nmol/l
0.7
0.8
0.96
39
425
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
53
1.70
0.75
2.2
2.0
nmol/l
13.0
16.5
—
9
47
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
76
894
0.84
0.74
6.2
8.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
69
817
0.84
0.73
2.7
3.5
mmol/l
24.9
24.0
1.23
54
733
(3044242) Glucose [Moles/volume] in Arterial blood
15
100
1.50
0.73
1.5
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
25
2.00
0.72
1.6
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
39
1.80
0.72
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
183
0.65
0.72
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
57
686
0.83
0.72
2.3
2.4
u/ml
0.4
0.4
0.73
28
391
(3045414) Leukocytes [Presence] in Urine
51
620
0.82
0.71
2.2
2.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
251
0.71
0.69
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
204
0.68
0.68
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
151
1677
0.89
0.68
2.0
2.4
e9/l
69.8
68.4
0.18
118
1298
(3016038) Potassium [Moles/volume] in Urine
18
127
1.42
0.68
1.2
1.2
mmol/l
33.8
35.7
0.15
18
110
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
168
0.65
0.67
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1413
13913
1.09
0.66
24.7
22.3
mmol/l
139.5
139.5
0.07
1365
13526
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
394
1.22
0.66
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
48
394
1.22
0.66
1.5
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
451
4753
0.93
0.65
3.1
3.2
mg/l
584.4
292.8
0.56
336
3036
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
482
0.80
0.65
1.4
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
213
0.70
0.65
1.5
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
741
0.84
0.64
2.5
2.5
g/l
3.9
3.8
0.34
43
523
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
281
0.74
0.64
2.0
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
514
4902
1.07
0.63
3.9
3.5
e6/l
83.0
88.1
0.07
409
3845
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
413
0.80
0.62
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
49
1.64
0.62
1.8
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1414
13935
1.08
0.62
24.4
22.5
mmol/l
4.0
4.0
3.93
1363
13530
(3022689) Creatine [Moles/volume] in Urine
5
30
1.67
0.61
1.2
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
312
0.77
0.61
1.1
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
20
0.00
0.60
0.0
14.8
—
5.9
—
0
20
(4027681)
8
51
1.57
0.60
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
22
289
0.76
0.60
1.4
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1049
10241
1.06
0.59
3.6
4.3
mm/h
16.1
15.4
0.64
930
9287
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
266
0.75
0.59
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
99
1117
0.88
0.59
1.3
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
22
0.00
0.59
0.0
5.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
247
2652
0.92
0.59
3.5
3.2
e6/l
3.4
2.2
0.83
134
1501
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
23
0.00
0.58
0.0
1.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
744
0.85
0.58
2.5
2.5
g/l
7.5
7.5
0.00
45
540
(3019230) Fractional oxyhemoglobin in Venous blood
21
276
0.76
0.58
2.2
2.1
%
54.2
60.5
0.57
21
276
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
242
0.74
0.58
1.6
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
42
346
1.22
0.57
1.3
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
743
0.86
0.57
2.5
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
160
0.69
0.55
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
18
134
1.35
0.53
1.1
1.2
e6/l
4239.8
157817.2
1.25
13
88
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
682
0.86
0.52
2.6
2.5
g/l
2.9
3.2
1.54
45
534
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
397
1.19
0.52
1.2
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
9
135
0.66
0.51
2.6
1.7
mg/l
2.9
4.9
—
9
130
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
89
791
1.13
0.51
1.8
1.9
ug/l
1.0
2.9
1.51
76
665
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
118
1.36
0.50
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
36
433
0.83
0.50
1.5
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
45
529
0.85
0.49
1.6
1.7
u/l
35.1
37.8
0.46
34
450
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
108
0.65
0.48
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
709
0.87
0.48
1.9
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
267
0.78
0.48
4.1
3.2
%
64.1
59.7
0.65
21
267
(3047181) Lactate [Moles/volume] in Blood
46
538
0.85
0.47
6.2
5.5
mmol/l
1.4
1.3
0.13
38
467
(3014765) Yersinia sp identified in Stool by Organism specific culture
47
401
1.18
0.47
1.2
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
255
0.78
0.47
2.9
2.9
e9/l
7.0
4.5
1.62
20
255
(3037556) Urate [Mass/volume] in Serum or Plasma
7
48
1.46
0.46
1.7
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1217
11975
1.06
0.46
5.0
4.9
mu/l
2.0
2.1
0.89
1099
10575
(42529406) Shigella sp [Presence] in Stool by Culture
47
403
1.17
0.45
1.2
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
31
372
0.83
0.43
1.5
1.6
e6/l
22206.0
17445.1
0.17
22
264
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
5
32
1.56
0.42
1.0
1.0
%
88.8
97.5
—
5
23
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
57
1.41
0.42
2.0
1.8
ug/l
106.6
54.2
—
8
52
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
1.7
—
0
16
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.0
—
10.7
—
0
7
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
104
0.67
0.39
1.0
1.1
—
5.6
—
0
5
(4212803)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
168
1571
1.08
0.39
2.4
2.6
g/l
67.4
66.0
1.76
150
1408
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
705
0.89
0.38
2.5
2.5
g/l
10.1
10.4
0.37
50
588
(3049717) Cytology report of Urine Cyto stain
67
746
0.89
0.37
2.0
2.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
28
333
0.84
0.37
1.3
1.8
mg/l
31.8
12.6
0.43
20
301
(3001019) Free T4 and TSH panel - Serum or Plasma
12
158
0.76
0.37
1.4
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
142
1522
0.93
0.36
4.6
6.2
mmol/l
9.7
11.5
2.59
133
1434
(4211845)
5
80
0.62
0.35
3.0
3.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
125
0.72
0.35
1.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
800
7835
1.04
0.34
3.9
6.1
umol/l
11.5
12.4
0.98
744
7389
(40758558) Short blood count panel - Blood
355
3419
1.05
0.33
5.5
6.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
87
0.69
0.33
2.5
3.9
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
89
0.67
0.33
1.2
1.4
%
79.2
64.9
—
6
65
(3037121) Protein [Mass/volume] in Urine
53
592
0.89
0.32
2.5
2.7
g/l
0.6
0.3
0.75
17
215
(3026782) Osmolality of Urine
345
3324
1.05
0.32
3.4
3.0
mosm/kgh2o
533.4
547.6
0.68
300
2817
(3045424) Erythrocytes [Presence] in Urine
17
208
0.82
0.31
1.5
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
53
1.32
0.31
3.9
2.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
207
0.82
0.30
1.6
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
108
0.74
0.29
1.0
1.1
%
145.3
115.2
—
8
97
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
260
1.16
0.29
4.7
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
43
384
1.12
0.28
5.3
4.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
375
0.88
0.27
4.0
3.8
mg/l
26.6
30.3
0.24
20
241
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
225
0.84
0.26
1.8
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
54
491
1.10
0.26
3.3
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
31
352
0.88
0.26
3.7
3.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
77
1.30
0.26
1.1
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
2.4
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
73
0.68
0.26
3.0
4.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
160
1.19
0.25
1.3
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
179
1.18
0.25
2.6
3.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
53
580
0.91
0.24
2.5
2.4
g/l
38.5
37.0
1.25
43
488
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
83
0.72
0.24
1.0
1.2
u/l
123.3
88.8
—
6
70
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
266
1.13
0.22
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
7
91
0.77
0.22
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
93
0.75
0.22
2.3
3.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
15
125
1.20
0.22
1.5
2.0
ug/l
5.0
2.8
0.66
15
111
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
153
1.18
0.22
1.2
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
225
2171
1.04
0.21
3.8
5.1
mmol/l
1.0
1.0
0.29
199
1982
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
107
1.22
0.21
2.5
2.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.3
—
0.3
—
0
11
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
6.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025315) Body weight
0
12
0.00
0.21
0.0
5.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010421) pH of Blood
51
469
1.09
0.21
4.7
4.6
ph
7.4
7.4
0.65
40
383
(3023420) DNA double strand Ab [Units/volume] in Serum
8
102
0.78
0.21
1.1
1.3
—
30.6
—
0
8
(4306422)
8
105
0.76
0.21
1.4
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
13
0.00
0.21
0.0
1.6
—
15.5
—
0
8
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
4775.9
—
0
8
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
86
913
0.94
0.20
4.0
8.2
mmol/l
24.5
24.4
0.07
80
836
(3007930) Methemoglobin/Hemoglobin.total in Blood
80
751
1.07
0.20
4.4
4.5
%
0.8
0.9
0.33
74
706
(1002224) Polysomnography panel
21
240
0.87
0.20
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
51
1.18
0.19
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
51
1.18
0.19
1.5
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
51
1.18
0.19
2.3
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
51
1.18
0.19
2.3
2.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
100
950
1.06
0.18
4.5
6.8
mmol/l
25.0
24.8
0.21
100
944
(3009508) Creatinine [Moles/volume] in Urine
469
4782
0.97
0.18
3.0
3.2
mmol/l
7.3
6.9
1.40
400
3870
(3024928) Oxygen saturation in Venous blood
33
361
0.91
0.17
1.8
2.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
69
0.72
0.17
1.4
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
69
0.72
0.17
2.6
1.8
e6/l
365.6
566.6
—
5
59
(3002523) Influenza virus A Ag [Presence] in Specimen
5
69
0.72
0.17
1.4
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
236
0.89
0.17
1.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
234
1.11
0.16
1.0
1.4
—
—
—
0
0
(44813793)
8
68
1.18
0.16
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
76
0.79
0.15
1.0
1.2
u/l
18.5
20.3
—
6
62
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
77
0.78
0.15
1.2
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
178
1.13
0.15
2.2
2.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
449
4418
1.02
0.14
2.2
2.3
mg/l
3.5
3.2
1.65
373
3704
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
97
0.82
0.13
1.3
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
80
764
1.05
0.13
4.4
4.4
%
1.5
1.6
0.16
74
718
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
151
1.13
0.13
1.2
1.3
pmol/l
273.7
251.8
—
10
115
(3004588) Protein electrophoresis panel - Serum or Plasma
138
1338
1.03
0.12
2.7
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
312
0.93
0.11
1.4
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
115
0.87
0.10
2.5
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
54
565
0.95
0.10
1.3
1.1
iu/ml
85.3
122.1
0.34
24
183
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
44
1.14
0.10
2.0
1.9
nmol/l
2.7
6.0
—
5
35
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
45
1.11
0.09
1.8
1.3
u/l
21.3
32.2
—
5
35
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
114
0.88
0.09
2.5
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
16
176
0.91
0.09
2.1
1.2
nmol/l
0.8
0.7
0.34
16
161
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
391
0.95
0.09
1.6
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
11
97
1.13
0.09
1.4
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1101
11063
0.99
0.09
5.6
7.6
u/l
78.4
82.0
1.21
1016
10283
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
390
0.95
0.08
3.2
2.3
g/l
131.5
125.6
0.69
30
283
(3026389) Candida sp identified in Specimen by Organism specific culture
17
185
0.92
0.08
1.2
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
65
0.77
0.08
2.6
1.9
e9/l
0.2
0.2
—
5
58
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
117
1.11
0.08
1.5
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
171
1742
0.98
0.08
4.9
3.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
68
1.03
0.07
3.1
1.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
135
1378
0.98
0.07
4.2
3.6
mmol/l
1.2
1.2
0.28
121
1183
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
255
0.94
0.07
1.8
1.5
iu/l
5.6
4.8
—
7
76
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
86
1.05
0.07
2.0
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
2.0
1.5
—
—
—
0
0
(4062490)
8
94
0.85
0.06
1.8
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
297
2937
1.01
0.06
1.5
1.6
mg/l
1.8
1.5
0.40
233
2290
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
61
629
0.97
0.06
3.2
2.6
g/l
0.7
1.4
1.62
52
525
(3035320) C reactive protein [Mass/volume] in Body fluid
9
103
0.87
0.06
2.3
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
121
1234
0.98
0.06
1.6
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
40
384
1.04
0.06
6.2
6.0
mmol/l
105.0
105.1
0.04
34
342
(3039000) Anion gap in Blood
40
384
1.04
0.06
6.2
6.0
mmol/l
11.0
11.1
0.14
34
342
(3007461) Platelets [#/volume] in Blood
1415
14118
1.01
0.06
28.7
27.1
e9/l
247.8
238.6
5.68
1362
13660
(3024731) MCV [Entitic volume]
1415
14118
1.01
0.06
28.7
27.1
fl
91.4
91.9
3.48
1369
13813
(3035941) MCH [Entitic mass]
1415
14119
1.01
0.06
28.7
27.0
pg
30.3
30.4
1.87
1371
13813
(3026361) Erythrocytes [#/volume] in Blood
1415
14120
1.01
0.05
28.8
27.2
e12/l
4.3
4.3
0.07
1359
13600
(21494890) Protein electrophoresis panel - 24 hour Urine
21
198
1.06
0.05
1.6
2.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1415
14122
1.01
0.05
29.0
27.3
g/l
130.6
131.0
0.40
1372
13821
(3004716) Salmonella sp identified in Stool by Organism specific culture
49
475
1.03
0.05
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1415
14123
1.01
0.05
28.8
27.2
e9/l
7.4
7.0
2.02
1364
13596
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
63
646
0.97
0.05
3.2
2.9
pmol/l
4.4
4.3
0.20
53
552
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
140
0.93
0.04
2.1
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
221
0.95
0.04
1.6
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
239
1.05
0.04
1.6
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
129
0.93
0.03
1.3
1.7
%
8.7
10.7
0.90
12
129
(3012501) Base excess in Blood by calculation
40
389
1.03
0.03
5.3
5.0
mmol/l
2.0
2.8
1.61
35
268
(4024509)
15
159
0.94
0.03
2.2
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
108
0.93
0.03
1.1
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
40
390
1.03
0.02
5.4
5.0
kpa
4.9
5.1
0.57
40
384
(3012095) Magnesium [Moles/volume] in Serum or Plasma
251
2524
0.99
0.02
2.2
2.9
mmol/l
0.8
0.8
0.26
221
2319
(3027315) Oxygen [Partial pressure] in Blood
40
391
1.02
0.02
5.4
5.0
kpa
8.4
8.2
0.52
40
385
(3000570) Elastase.pancreatic [Mass/mass] in Stool
43
438
0.98
0.01
1.4
1.5
ug/g
281.6
267.6
0.15
20
262
(4146454)
18
173
1.04
0.01
2.9
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
564
5651
1.00
0.01
4.5
5.7
ug/l
3.5
4.6
0.62
485
4964
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
106
0.94
0.01
1.9
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
126
0.95
0.00
1.2
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
136
0.96
0.00
1.3
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
121
1204
1.01
0.00
2.2
2.0
nmol/l
368.1
379.7
0.28
108
1075
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
583
5836
1.00
0.00
2.1
2.2
nmol/l
78.0
79.9
0.79
497
4998
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
145
0.97
0.00
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
185
0.97
0.00
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
46
465
0.99
0.00
3.0
3.4
mmol/l
24.1
25.2
0.95
41
398
(3025941) Bacteria identified in Stool by Culture
67
672
1.00
0.00
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
162
0.99
0.00
1.7
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
112
0.98
0.00
10.2
14.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
182
0.99
0.00
1.9
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
152
0.99
0.00
2.3
1.2
nmol/l
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
383
0.99
0.00
3.7
2.6
%
16.6
15.5
0.78
20
187
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
33.2
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
2.3
—
0
5
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
6
64
0.94
0.00
4.3
2.3
ml
1443.3
1871.6
—
6
54
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
64
0.94
0.00
9.5
5.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
4.6
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
17.9
—
0
5
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.5
—
0
6
(1175426) CD3 cells/100 lymphocytes in Blood
7
72
0.97
0.00
3.1
1.8
%
80.1
72.2
—
7
65
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
33.1
—
0
5
(3025130) Human papilloma virus identified in Specimen
5
54
0.93
0.00
2.4
1.9
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
56
0.89
0.00
2.4
1.2
mmol/l
6.4
6.5
—
5
56
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
370
1.00
0.00
1.6
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
-0.00
0.0
8.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HCNP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCNP | 2.238 [2.01, 2.49] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.32 |
During the follow-up period (1.1.1998 — 31.12.2019), 1631 out of 3345 females with G6_HCNP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCNP | 2.381 [2.07, 2.74] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 1722 out of 3293 males with G6_HCNP died.
Mortality risk
Mortality risk for people of age
years, who have G6_HCNP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.211% | 0.473% |
| 5 | 1.38% | 2.537% |
| 10 | 3.1% | 6.356% |
| 15 | 6.083% | 11.522% |
| 20 | 11.154% | 18.816% |
Relationships between endpoints
↥Index endpoint: G6_HCNP – Normal-pressure hydrocephalus
GWS hits: 13
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data